KKR is said to consider selling USD 750 million stake in JB Pharma: Bloomberg Ruchika Sharma7 Nov 2024 2:30 PM ISTKKR & Co., the U.S.-based private equity giant, is exploring a partial divestment of its controlling stake in JB Chemicals & Pharmaceuticals...
JB Pharma secures USFDA nod for anxiety drug Ruchika Sharma24 Aug 2023 12:30 PM ISTThe drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat.
JB Pharma PAT rises 3.5 percent to Rs 88 crore in Q4 Ruchika Sharma25 May 2023 3:30 PM ISTNew Delhi: JB Pharma on Wednesday said its profit after tax rose by 3.5 per cent to Rs 88 crore for the fourth quarter ended March 31, 2023.The...
JB Pharma reports revenue growth of 32 percent to Rs 793 crores in Q3 FY23 Ruchika Sharma9 Feb 2023 1:15 PM ISTRs 2387 Crores revenue recorded for nine months of FY23
JB Pharma acquires leading brand of Rosuvastatin- Razel and combinations Dr. Nandita Mohan20 Dec 2022 1:05 PM ISTNew Delhi: Leading brand of Rosuvastatin, Razel will now be offered from JB Pharma as the company has now entered into an agreement with Glenmark...
JB Pharma forays into Statin segment, acquires Razel franchise from Glenmark for Rs 314 crore Ruchika Sharma15 Dec 2022 4:00 PM ISTNew Delhi: JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals...
JB Pharma bags USFDA nod for Major Depressive Disorder drug Venlafaxine Extended Release Ruchika Sharma30 Nov 2022 3:30 PM ISTA selective serotonin and norepinephrine reuptake inhibitor (SNRI), Venlafaxine Extended-Release tablets are indicated for Major Depressive Disorder...
JB pharma strengthens its position in gastroenterology with launch of RANRAFT Roshni Dhar8 Nov 2022 6:00 PM ISTGastroesophageal reflux disease (GERD), affects up to 1 in 5 Indian patients, causes heartburn, acid reflux and impacts the quality of life. It is...
Health Bulletin 8/November/2022 Roshni Dhar8 Nov 2022 4:58 PM ISTHere are the top health news for the day:Doctors protest against bond policy escalates across the country, Haryana cancels NEET counsellingThe MBBS...
JB Pharma strengthens its position in Gastroenterology with launch of RANRAFT Lalhmangaihkimi7 Nov 2022 1:54 PM ISTMumbai: Gastroesophageal reflux disease (GERD), affects up to 1 in 5 Indian patients, causes heartburn, acid reflux and impacts the quality of life....
JB Pharma records revenue growth of 30 percent to Rs 785 crores in Q1 Ruchika Sharma5 Aug 2022 1:45 PM ISTDomestic Business records highest ever sales in a quarter of INR 418 crore registering growth of 34%, while organic revenues from the domestic...
